Publications

Export 9702 results:
Sort by: Author [ Title  (Asc)] Type Year
A B [C] D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
C
AK, S., H. A, R. A, S. N, and R. S, "C- MAC videolaryngeoscopy versus flexible fiberoptic laryngeoscopy in patient with anticipated difficult intubation. A randomized controlled trial", Journal of anesthesia and critical care, vol. 1, issue 1, pp. 101, 2015. downloadfile-1.pdf
Hassaneen, H. M., and H. A. H. Mousa, "C-(2-Thinyl)-N-Arylformohydrazidoyl Chlorides in the Synthesis of Selenadiazolines and Thiadiazolines.", Sulfur Letters, vol. 7, pp. 93-102 , 1988.
E, A., and H. H, "C-Kit (Cd117) Expression In Benign And Malignant Epithelial Salivary Gland Tumors", Egyptian Journal of Pathology, vol. 27, issue No. 1, June, 2007.
Maher, M., N. Allahloubi, S. Salem, N. Habashy, E. El-Desouky, M. M. Elserafy, and A. Bahnassy, "C-Kit and MSI in stage II colorectal cancer: Incidence and prognosis in Egyptian patients", Annals of Oncology, vol. 28: Elsevier, pp. iii97, 2017. Abstract
n/a
Mohamed, S. A., and R. E. Hawary, "C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Critically Ill Pediatric Patients", journal of child science, vol. 10, pp. e1–e11., 2020. crp_alb_published_paper.pdf
Mohamed, S. A., and R. E. Hawary, "C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Critically Ill Pediatric Patients", Journal of Child Science, vol. 10, issue 1, 2020.
Shoaeb, M. A., M. A. Shehata, K. M. Taema, and M. A. Hammouda, "C-Reactive Protein: A Potential Biomarker for Differentiating Ischemic from Hemorrhagic Stroke", Egypt J Neurol Psychiatric Neurosurg, vol. 51, issue 3, pp. 311-320, 2014.
Taema, K. M., and E. El-kholy, "C-Reactive Protein: A Potential Biomarker for Length of Stay Prediction in Critically Ill Patients", Med J Cairo Univ., vol. 82, issue 2, pp. 69-75, 2014.
, c.v, , 2015. lsm.doc
Abou-Elella, F. M., E. A. Hanafy, M. T. Maoud, H. A. Kassem, and N. M. Kassem, "C/EBPa as a biomarker gene in cancer cell and its relation to natural anticancer compounds", Plant Archives, vol. 19, issue 2, pp. 2693-2700, 2019. cebpa_as_a_biomarker_gene_in_cancer_cell_and_its_relation_to_natural_anticancer_compounds.pdf
M., A. - E. F., H. E. A., M. M. T., H. A. Kassem, and N. M. Kassem, "C/EBPA AS A BIOMARKER GENE IN CANCER CELL AND ITS RELATION TO NATURAL ANTICANCER COMPOUNDS", Plant Archives, vol. 19, issue 2, pp. 2693-2700, 2019.
Abou-Elella, F. M., E. A. Hanafy, M. T. Maoud, M. T. Maoud, H. A. Kassem, and N. M. Kassem, "C/EBPA AS A BIOMARKER GENE IN CANCER CELL AND ITS RELATION TO NATURAL ANTICANCER COMPOUNDS", Plant Archives , vol. 19, issue 2, pp. 2693-2700, 2019. cebpa_as_a_biomarker_gene_in_cancer_cell_and_its.pdf
El_Saadany, Z. A., N. B. Fouad, A. A. Alshaqanqery, and N. S. Ibrahim, "C/EBPα Expression in Egyptian patients with Acute Myeloid Leukemia", Pan Arab Journal of Oncology, vol. 3, issue 4, pp. 8-13, 2010. Abstract

Purpose: The CCAAT/enhancer binding protein alpha (C/EBPα or CEBPA) transcription factor plays an important role in myeloid differentiation. Alterations in C/EBPα levels have been described in AML.
Patients and methods: We studied the C/EBPα expression level by real-time
PCR in 49 newly diagnosed AML patients.
Results: Low C/EBPα expression was observed in 40/49 (81.7%, median 0.018) compared to normal subjects (median 1.26) (p = 0.001). We observed that low C/EBPα expression was associated with low hemoglobin level (p = 0.001), high HLA-DR expression (p=0.013) and poor disease free survival (DFS) and overall survival (OS).
Conclusion: low C/EBPα expression defined a subgroup of AML patients with poor DFS and OS, so can be used with other markers to assess prognosis of AML patients.

Saadany, Z. E. A., N. B. Fouad, A. A. Alshaqanqery, and N. S. Ibrahim, "C/EBPα Expression in Egyptian patients with Acute Myeloid Leukemia", Pan Arab Journal o f Oncology, vol. 3, issue 4, pp. 8 - 12, 2010.
Amin, I., Y. Ibrahim, and M. Yousif, "C3-modules", Algebra Colloquium, vol. 22, issue 4, pp. 655-670 , 2015.
Sholkamy, A., and C. 4 contributors, "C4 article: Implications of COVID-19 in transplantation", American J of Transplantation, vol. 21, issue 5, pp. 1801-1815, 2021.
Ozarslan, M. A. -, Y. Ibrahim, C. Ozcan, and M. Yousif, "C4- and D4-Modules via Perspective Direct Summands", Communications In Algebra, vol. 46, issue 10, pp. 4480–4497, 2018.
Ding, N., Y. Ibrahim, M. Yousif, and Y. Zhou, "C4-Modules", Communications in Algebra, vol. 45, issue 4, pp. 1727–1740, 2017.
Ibrahim, Y., and M. Yousif, "C4-MODULES WITH THE EXCHANGE PROPERTY", Communications in Algebra, In Press.
Aldoasri, M. A., N. A. Elmarzugi, S. S. Darwish, M. A. Adam, N. Al-Mouallimi, and S. M. Ahmed, "Ca (OH)2Nanoparticles Based on Acrylic Copolymers for the consolidation and protection of Ancient Egypt Calcareous Stone Monuments", Applied Nanotechnology and Nanoscience International Conference 2016 , Barcelona, Spain, IOP Conf. Series: Journal of Physics: Conf. Series 829 , pp. 1-9, 2017.
Al-Dosari, M. A., S. S. Darwish, M. A. Adam, N. A. Elmarzugi, N. Al-Mouallimi, and S. M. Ahmed, "Ca (OH)2Nanoparticles Based on Acrylic Copolymers for the consolidation and protection of Ancient Egypt Calcareous Stone Monuments", Journal of Physics, vol. 829 , issue 829 (2017) 012009, pp. 1-9, 2017. paper_6.pdf
EL GAWAD, I. M. A. N. A. B. D. A., and H. E. Shafik, "CA 125, a new prognostic marker for aggressive NHL", J Egypt Natl Canc Inst, vol. 21, issue 3, pp. 209-17, 2009. Abstract
n/a
A.L.Aboul-Nasr, and S.Sharawi, "CA 125, CA 19-9 and CEA in benign gynecologic tumors: Effect of surgery. ", Med. J. Cairo Univ., vol. 60, issue 3, pp. 843-850, 1992.
Tourism